Aripiprazole for clozapine associated medical morbidity

Trial Profile

Aripiprazole for clozapine associated medical morbidity

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Sep 2012

At a glance

  • Drugs Aripiprazole (Primary) ; Clozapine
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Sep 2012 Results published in the Acta Psychiatrica Scandinavica.
    • 01 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Jul 2008 The expected completion date for this trial is now 1 Oct 2009, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top